Advances in Haemostatic Sponges: Characteristics and the Underlying Mechanisms for Rapid Haemostasis
Overview
Affiliations
In traumatized patients, the primary cause of mortality is uncontrollable continuous bleeding and unexpected intraoperative bleeding which is likely to increase the risk of complications and surgical failure. High expansion sponges are effective clinical practice for the treatment of wound bleeding (irregular/deep/narrow) that are caused by capillaries, veins and even arterioles as they possess a high liquid absorption ratio so can absorb blood platelets easily in comparison with traditional haemostasis treatments, which involve compression, ligation, or electrical coagulation etc. When in contact with blood, haemostatic sponges can cause platelet adhesion, aggregation, and thrombosis, preventing blood from flowing out from wounds, triggering the release of coagulation factors, causing the blood to form a stable polymerized fibre protein, forming blood clots, and achieving the goal of wound bleeding control. Haemostatic sponges are found in a variety of shapes and sizes. The aim of this review is to facilitate an overview of recent research around haemostatic sponge materials, products, and technology. This paper reviews the synthesis, properties, and characteristics of haemostatic sponges, together with the haemostasis mechanisms of haemostatic sponges (composite materials), such as chitosan, cellulose, gelatin, starch, graphene oxide, hyaluronic acid, alginate, polyethylene glycol, silk fibroin, synthetic polymers silver nanoparticles, zinc oxide nanoparticles, mesoporous silica nanoparticles, and silica nanoparticles. Also, this paper reviews commercial sponges and their properties. In addition to this, we discuss various in-vitro/in-vivo approaches for the evaluation of the effect of sponges on haemostasis.
Wu Z, Shi Y, Zhang B, Liu H, Zhang P ACS Omega. 2025; 10(3):2986-2995.
PMID: 39895763 PMC: 11780408. DOI: 10.1021/acsomega.4c06103.
Smart design in biopolymer-based hemostatic sponges: From hemostasis to multiple functions.
Zou C, Han C, Xing F, Jiang Y, Xiong M, Li-Ling J Bioact Mater. 2024; 45:459-478.
PMID: 39697242 PMC: 11653154. DOI: 10.1016/j.bioactmat.2024.11.034.
Razali R, Muhammad Firdaus F, Fauzi M, Mobarak N, Aminuddin S, Lokanathan Y Polymers (Basel). 2024; 16(23).
PMID: 39684132 PMC: 11644748. DOI: 10.3390/polym16233387.
Local and Systemic Hemostatic Agents: A Comprehensive Review.
Jamali B, Nouri S, Amidi S Cureus. 2024; 16(10):e72312.
PMID: 39583426 PMC: 11585330. DOI: 10.7759/cureus.72312.
Zhang Y, Li M, Chang J, Li C, Hui Y, Wang Y Burns Trauma. 2024; 12:tkae026.
PMID: 39403685 PMC: 11471902. DOI: 10.1093/burnst/tkae026.